President Trump’s self-branded attempt to cut drug prices, TrumpRx, is set to launch within weeks, offering a novel pathway ...
Chief Executive Officer Bob Bradway told attendees at a J.P. Morgan-hosted event that the company views 2026 as a ...
Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback